EUVIMEDEUVIMED entdecken
Crossref

Synthesis and Evaluation of [ 11 C]MCC950 for Imaging NLRP3-Mediated Inflammation in Atherosclerosis

Uzair S Ismailani, Ariel Buchler, Nicole MacMullin, Faduma Abdirahman, Myriam Adi iD, Benjamin H Rotstein iD

Molecular Pharmaceutics · 2023

DOI: 10.1021/acs.molpharmaceut.2c00915 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2023. Verfasst von Uzair S Ismailani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Atherosclerosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: CIHR, Canada Foundation for Innovation, Institute of Circulatory and Respiratory Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinAtherosclerosisAnimalsMiceSulfonesDisease Models, AnimalMice, Inbred C57BLSulfonamidesInflammasomesInflammationApolipoproteins E

Stichwörter der Autor:innen

CO2-fixationMCC950NOD-like receptor pyrin domain-containing protein 3 (NLRP3)atherosclerosisautoradiographycarbon-11molecular imagingpositron emission tomography

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinSulfonesSulfonamidesInflammasomesApolipoproteins ENlrp3 protein, mouse

Autor:innen und Institutionen

  • Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada.
  • University of Ottawa Heart Institute, Ottawa, Ontario K1Y 4W7, Canada.
  • Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, Ontario K1N 6N5, Canada.

ORCID-Profile: Myriam Adi, Benjamin H Rotstein

Förderung

  • CIHR
  • Canada Foundation for Innovation
  • Institute of Circulatory and Respiratory Health
  • Natural Sciences and Engineering Research Council of Canada
  • Ministry of Research and Innovation

Zitieren

APA

Ismailani, U. S., Buchler, A., MacMullin, N., Abdirahman, F., Adi, M., & Rotstein, B. H. (2023). Synthesis and Evaluation of [ 11 C]MCC950 for Imaging NLRP3-Mediated Inflammation in Atherosclerosis. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.2c00915

Vancouver

Ismailani US, Buchler A, MacMullin N, Abdirahman F, Adi M, Rotstein BH. Synthesis and Evaluation of [ 11 C]MCC950 for Imaging NLRP3-Mediated Inflammation in Atherosclerosis. Molecular Pharmaceutics. 2023. doi:10.1021/acs.molpharmaceut.2c00915

BibTeX
@article{Ismailani2023,
  author = {Ismailani, Uzair S and Buchler, Ariel and MacMullin, Nicole and Abdirahman, Faduma and Adi, Myriam and Rotstein, Benjamin H},
  title = {Synthesis and Evaluation of [ 11 C]MCC950 for Imaging NLRP3-Mediated Inflammation in Atherosclerosis},
  journal = {Molecular Pharmaceutics},
  year = {2023},
  doi = {10.1021/acs.molpharmaceut.2c00915}
}
Kostenlos starten →